MU

Mohanasundaram Umarani

Active Director Designated Partner DIN 09392835
DIN 09392835 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohanasundaram Umarani

Data last updated:

Mohanasundaram Umarani is a Designated Partner at Bonn Stering Bio Science Llp (since 2021). The company operates in Pharma.

DIN 09392835
Primary Designation Designated Partner
Industry Pharma
First Appointment 18 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Nov 20212021Active

Board colleagues of Mohanasundaram Umarani

Directorship timeline

Open interactive timeline →
Bonn Stering Bio Science Llp
Premium access

Shareholding and investment profile for Mohanasundaram Umarani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohanasundaram Umarani

Mohanasundaram Umarani currently holds 1 directorship: Bonn Stering Bio Science Llp (Designated Partner, since 18 Nov 2021).

Mohanasundaram Umarani was first appointed on 18 Nov 2021 as Designated Partner at Bonn Stering Bio Science Llp.

The current boards of Mohanasundaram Umarani's companies include Bharathidhasan (Bonn Stering Bio Science Llp), Madhu Mathi (Bonn Stering Bio Science Llp), Rada Ragunathan (Bonn Stering Bio Science Llp), Raghunaathan Ramaswamy (Bonn Stering Bio Science Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available